B.C.’s biosimilars policy a turning point for private plans.
B.C.’s Biosimilars Initiative has had a profound impact on private drug plans. By the end of 2020, biosimilars’ share of...
B.C.’s Biosimilars Initiative has had a profound impact on private drug plans. By the end of 2020, biosimilars’ share of...